Repetitive mild traumatic brain injury augments tau pathology and glial activation in aged hTau mice

Journal of Neuropathology and Experimental Neurology

Volumn 72, Issue 2, 2013, Pages 137-151

  Ojo, Joseph Olubunmi ^a   Mouzon, Benoit ^a   Greenberg, M Banks ^a   Bachmeier, Corbin ^a   Mullan, Mike ^a   Crawford, Fiona ^a  

^a ROSKAMP INSTITUTE   (United States)

Author keywords

Aging; Chronic traumatic encephalopathy; Glia; Human tau; Mild traumatic brain injury; Phospho tau.

Indexed keywords

TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; CORPUS CALLOSUM; GLIA CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROGLIA; MOTOR CORTEX; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; SOMATOSENSORY CORTEX; TRAUMATIC BRAIN INJURY;

AGE FACTORS; ANIMALS; ANTIGENS, CD45; APOPTOSIS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; EPITOPES; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; TAU PROTEINS; TAUOPATHIES; TRANSCRIPTION FACTORS;

EID: 84872853238     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182814cdf     Document Type: Article

References (71)

1. Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: A brief overview. J Head Trauma Rehabil 2006;21:375-78
2. Nowinski C. Head Games: Football's Concussion Crisis From the NFL to Youth Leagues. East Bridgewater, MA: Drummond Publishing Group, 2006
3. Webbe FM, Barth JT. Short-term and long-term outcome of athletic closed head injuries. Clin Sports Med 2003;22:577-92
4. Omalu BI, DeKosky ST, Hamilton RL, et al. Chronic traumatic encephalopathy in a national football league player: Part II. Neurosurgery 2006;59:1086-192
5. Omalu BI, DeKosky ST, Minster RL, et al. Chronic traumatic encephalopathy in a National Football League player. Neurosurgery 2005;57: 128-34
6. Omalu BI, Bailes J, Hamilton RL, et al. Emerging histomorphologic phenotypes of chronic traumatic encephalopathy in American athletes. Neurosurgery 2011;69:173-83
7. Geddes JF, Vowles GH, Robinson SF, et al. Neurofibrillary tangles, but not Alzheimer-type pathology, in a young boxer. Neuropathol Appl Neurobiol 1996;22:12-16
8. McKee AC, Cantu RC, Nowinski CJ, et al. Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 2009;68:709-35
9. Martland HS. Punch drunk. JAMA 1928;91:1103-7
10. Millspaugh JA. Dementia pugilistica. US Naval Med Bull 1937;35:297-303
11. Corsellis JA, Bruton CJ, Freeman-Browne D. The aftermath of boxing. Psychol Med 1973;3:270-303
12. Grahmann H, Ule G. Diagnosis of chronic cerebral symptoms in boxers (dementia pugilistica and traumatic encephalopathy of boxers) [In German]. Psychiatr Neurol (Basel) 1957;134:261-83
13. Critchley M. Medical aspects of boxing, particularly from a neurological standpoint. Br Med J 1957;1:357-62
14. Hall RC, Chapman MJ. Definition, diagnosis and forensic implications of postconcussional syndrome. Psychosomatics 2005;46:195-202
15. Shively S, Scher AI, Perl DP, et al. Dementia resulting from traumatic brain injury: What is the pathology? Arch Neurol 2012;69:1245-51
16. Roberts A. Brain Damage in Boxers: A Study of the Prevalence of Traumatic Encephalopathy Among Ex-Professional Boxers. London, UK: Pitman Medical and Scientific Publishing, 1969
17. Hof PR, Bouras C, Buee L, et al. Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta Neuropathol 1992;85:23-30
18. Geddes JF, Vowles GH, Nicoll JA, et al. Neuronal cytoskeletal changes are an early consequence of repetitive head injury. Acta Neuropathol 1999;98: 171-78
19. Tokuda T, Ikeda S, Yanagisawa N, et al. Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid betaprotein and tau protein. Acta Neuropathol 1991;82:280-85
20. Zetterberg H, Hietala A, Jonsson M, et al. Neurochemical aftermath of amateur boxing. Arch Neurol 2006;63:1277-80
21. Johnson VE, Stewart W, Smith DH. Widespread tau and amyloid-Beta pathology many years after a single traumatic brain injury in humans. Brain Pathol 2012;22:142-49
22. Johnson VE, Stewart W, Trojanowski JQ, et al. Acute and chronically increased immunoreactivity to phosphorylation-independent but not pathological TDP-43 after a single traumatic brain injury in humans. Acta Neuropathol 2011;122:715-26
23. Ikonomovic MD, Uryu K, Abrahamson EE, et al. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol 2004;190:192-203
24. Smith C, Graham DI, Murray LS, et al. Tau immunohistochemistry in acute brain injury. Neuropathol Appl Neurobiol 2003;29:496-502
25. Tran HT, LaFerla FM, Holtzman DM, et al. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-beta accumulation and independently accelerates the development of tau abnormalities. J Neurosci 2011;31:9513-25
26. Tran HT, Sanchez L, Esparza TJ, et al. Distinct temporal and anatomical distributions of amyloid-beta and tau abnormalities following controlled cortical impact in transgenic mice. PLoS One 2011;6:e25475
27. Tran HT, Sanchez L, Brody DL. Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice. J Neuropathol Exp Neurol 2012;71:116-29
28. Uryu K, Laurer H, McIntosh T, et al. Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J Neurosci 2002;22:446-54
29. Yoshiyama Y, Uryu K, Higuchi M, et al. Enhanced neurofibrillary tangle formation, cerebral atrophy, and cognitive deficits induced by repetitive mild brain injury in a transgenic tauopathy mouse model. J Neurotrauma 2005;22:1134-41
30. Andorfer C, Kress Y, Espinoza M, et al. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem 2003;86:582-90
31. Andorfer C, Acker CM, Kress Y, et al. Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J Neurosci 2005;25:5446-54
32. Polydoro M, Acker CM, Duff K, et al. Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. J Neurosci 2009;29:10741-49
33. Alldred MJ, Duff KE, Ginsberg SD. Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction. Neurobiol Dis 2011;45:751-62
34. Mouzon B, Chaytow H, Crynen G, et al. Repetitive mild traumatic brain injury in a mouse model produces learning and memory deficits accompanied by histological changes. Neurotrauma 2012;29:2761-73
35. Planel E, Richter KE, Nolan CE, et al. Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci 2007;27:3090-97
36. Paxinos G, Franklin KBJ. The Mouse Brain in Stereotactic Co-Ordinates. 2nd Ed. San Diego, CA: Academic Press, 2001
37. Gallyas F. A principle for silver staining of tissue elements by physical development. Acta Morphol Acad Sci Hung 1971;19:57-71
38. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 1971;19:1-8
39. Kimura T, Ono T, Takamatsu J, et al. Sequential changes of tau-siteY specific phosphorylation during development of paired helical filaments. Dementia 1996;7:177-81
40. Duff K, Knight H, Refolo LM, et al. Characterization of pathology in transgenic mice overexpressing human genomic and cDNA tau transgenes. Neurobiol Dis 2000;7:87-98
41. Augustinack JC, Schneider A, Mandelkow EM, et al. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 2002;103:26-35
42. Otvos L Jr, Feiner L, Lang E, et al. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 1994;39:669-73
43. Mavrogiorgou P, Gertz HJ, Ferszt R, et al. Are routine methods good enough to stain senile plaques and neurofibrillary tangles in different brain regions of demented patients? Psychiatr Danub 2011;23: 334-39
44. Iwakiri M, Mizukami K, Ikonomovic MD, et al. An immunohistochemical study of GABA A receptor gamma subunits in Alzheimer's disease hippocampus: Relationship to neurofibrillary tangle progression. Neuropathology 2009;29:263-69
45. Ojo B, Rezaie P, Gabbott PL, et al. A neural cell adhesion moleculederived peptide, FGL, attenuates glial cell activation in the aged hippocampus. Exp Neurol 2011;232:318-28
46. Amenta F, Bronzetti E, Sabbatini M, et al. Astrocyte changes in aging cerebral cortex and hippocampus: A quantitative immunohistochemical study. Microsc Res Tech 1998;43:29-33
47. Geinisman Y, Bondareff W, Dodge JT. Hypertrophy of astroglial processes in the dentate gyrus of the senescent rat. Am J Anat 1978;153: 537-43
48. Cosenza-Nashat MA, Kim MO, Zhao ML, et al. CD45 isoform expression in microglia and inflammatory cells in HIV-1 encephalitis. Brain Pathol 2006;16:256-65
49. Cosenza MA, Zhao ML, Si Q, et al. Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol 2002;12:442-55
50. Henry CJ, Huang Y, Wynne AM, et al. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav Immun 2009;23; 309-17
51. Blau CW, Cowley TR, O'Sullivan J, et al. The age-related deficit in LTP is associated with changes in perfusion and blood-brain barrier permeability. Neurol Aging 2012;33:1005.e23-35
52. Schmidt ML, Zhukareva V, Newell KL, et al. Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease. Acta Neuropathol 2001;101:518-24
53. Oddo S, Caccamo A, Shepherd JD, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 2003;39:409-21
54. Mazanetz MP, Fischer PM. Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases. Nat Rev Drug Discov 2007;6: 464-79
55. Chen LJ, Wang YJ, Tseng GF. Compression alters kinase and phosphatase activity and tau and MAP2 phosphorylation transiently while inducing the fast adaptive dendritic remodeling of underlying cortical neurons. J Neurotrauma 2010;27:1657-69
56. Majetschak M, King DR, Krehmeier U, et al. Ubiquitin immunoreactivity in cerebrospinal fluid after traumatic brain injury: Clinical and experimental findings. Crit Care Med 2005;33:1589-94
57. Yao X, Liu J, McCabe JT. Alterations of cerebral cortex and hippocampal proteasome subunit expression and function in a traumatic brain injury rat model. J Neurochem 2008;104:353-63
58. Liu L, Drouet V, Wu JW, et al. Transsynaptic spread of tau pathology in vivo. PLoS One 2012;7:e31302
59. Harris FM, Brecht WJ, Xu Q, et al. Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: Modulation by zinc. J Biol Chem 2004; 279:44795-801
60. Eckenhoff RG, Planel E. Postoperative cognitive decline: Where art tau? Anesthesiology 2012;116:751-52
61. Papon MA, Whittington RA, El-Khoury NB, et al. Alzheimer's disease and anesthesia. Front Neurosci 2011;4:272
62. Kane MJ, Angoa-Perez M, Briggs DI, et al. A mouse model of human repetitive mild traumatic brain injury. J Neurosci Methods 2011;203: 41-49
63. Homsi S, Piaggio T, Croci N, et al. Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: A twelve-week follow-up study. J Neurotrauma 2010;27:911-21
64. Bennett RE, Mac Donald CL, Brody DL. Diffusion tensor imaging detects axonal injury in a mouse model of repetitive closed-skull traumatic brain injury. Neurosci Lett 2012;513:160-65
65. Blaylock RL, Maroon J. Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathyVA unifying hypothesis. Surg Neurol Int 2011;2:107
66. Myer DJ, Gurkoff GG, Lee SM, et al. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 2006;129:2761-72
67. Sofroniew MV. Reactive astrocytes in neural repair and protection. Neuroscientist 2005;11:400-7
68. Dilger RN, Johnson RW. Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J Leukoc Biol 2008;84:932-39
69. von Bernhardi R, Tichauer JE, Eugenin J. Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders. J Neurochem 2010;112:1099-114
70. Polydoro M, Acker CM, Duff K, et al. Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. J Neurosci 2009;29:10741-49
71. Planel E, Richter KE, Nolan CE, et al. Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci 2007;27:3090-97